|
US5753664A
(en)
*
|
1995-03-16 |
1998-05-19 |
Takeda Chemical Industries, Ltd. |
Heterocyclic compounds, their production and use
|
|
FR2734814B1
(fr)
|
1995-05-31 |
1997-07-04 |
Adir |
Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
|
CA2242425C
(en)
|
1996-02-13 |
2006-07-18 |
Zeneca Limited |
Quinazoline derivatives as vegf inhibitors
|
|
NZ331191A
(en)
|
1996-03-05 |
2000-03-27 |
Zeneca Ltd |
4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
|
|
US5928323A
(en)
|
1996-05-30 |
1999-07-27 |
Sun Microsystems, Inc. |
Apparatus and method for dynamically generating information with server-side software objects
|
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
|
BR9808398A
(pt)
|
1997-03-21 |
2000-05-16 |
Novartis Ag |
Derivados pirazol com atividade herbicida
|
|
GB9714249D0
(en)
|
1997-07-08 |
1997-09-10 |
Angiogene Pharm Ltd |
Vascular damaging agents
|
|
FR2783519B1
(fr)
|
1998-09-23 |
2003-01-24 |
Sod Conseils Rech Applic |
Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
|
|
GB9900334D0
(en)
|
1999-01-07 |
1999-02-24 |
Angiogene Pharm Ltd |
Tricylic vascular damaging agents
|
|
GB9900752D0
(en)
|
1999-01-15 |
1999-03-03 |
Angiogene Pharm Ltd |
Benzimidazole vascular damaging agents
|
|
EE05345B1
(et)
|
1999-02-10 |
2010-10-15 |
Astrazeneca Ab |
Kinasoliini derivaadid angiogeneesi inhibiitoritena
|
|
BR0111230A
(pt)
|
2000-05-31 |
2003-06-10 |
Astrazeneca Ab |
Composto, e, uso e processo para a preparação do mesmo
|
|
UA73993C2
(uk)
|
2000-06-06 |
2005-10-17 |
Астразенека Аб |
Хіназолінові похідні для лікування пухлин та фармацевтична композиція
|
|
EE200300015A
(et)
|
2000-07-07 |
2004-10-15 |
Angiogene Pharmaceuticals Limited |
Kolhinooli derivaadid kui angiogeneesi inhibiitorid
|
|
KR20030014425A
(ko)
|
2000-07-07 |
2003-02-17 |
앤지오젠 파마슈티칼스 리미티드 |
혈관 손상제인 콜치놀 유도체
|
|
JP2004531471A
(ja)
|
2000-12-21 |
2004-10-14 |
グラクソ グループ リミテッド |
マクロライド抗生物質
|
|
CA2438318A1
(en)
|
2001-02-16 |
2002-08-29 |
Aventis Pharmaceuticals Inc. |
Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
|
|
US7169795B2
(en)
|
2003-09-30 |
2007-01-30 |
Bristol Myers Squibb Company |
Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
|
|
US20050261201A1
(en)
|
2004-03-30 |
2005-11-24 |
Rejuvenon Corporation |
Method of reducing C-reactive protein using growth hormone secretagogues
|
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
|
MX2007015772A
(es)
|
2005-06-17 |
2008-02-22 |
Wyeth Corp |
Compuestos utiles como inhibidores de serotonina y agonistas y antagonistas de 5-ht-1a.
|
|
JP5094725B2
(ja)
|
2005-10-04 |
2012-12-12 |
イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ |
Ｈｉｖインテグラーゼ阻害剤
|
|
HRP20100194T8
(hr)
|
2005-10-21 |
2010-06-30 |
Glaxo Group Limited |
Perikondenzirani triciklički spojevi, korisni kao antibakterijska sredstva
|
|
US8247556B2
(en)
*
|
2005-10-21 |
2012-08-21 |
Amgen Inc. |
Method for preparing 6-substituted-7-aza-indoles
|
|
CN102633783A
(zh)
|
2006-02-10 |
2012-08-15 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
JP5415942B2
(ja)
|
2006-06-22 |
2014-02-12 |
プラナ バイオテクノロジー リミティッド |
処置の方法およびその処置に有用な薬剤
|
|
WO2008016666A2
(en)
|
2006-08-02 |
2008-02-07 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions, and methods
|
|
ES2420479T3
(es)
*
|
2006-08-31 |
2013-08-23 |
Sk Chemicals, Co., Ltd. |
Procedimiento para la producción de microesferas cargadas con fármacos y microesferas cargadas con fármacos producidas mediante el mismo
|
|
WO2008074068A1
(en)
|
2006-12-20 |
2008-06-26 |
Prana Biotechnology Limited |
Substituted quinoline derivatives as antiamyloidogeneic agents
|
|
AR064517A1
(es)
|
2006-12-22 |
2009-04-08 |
Avexa Ltd |
Pirimidinionas biciclicas y sus usos
|
|
CN101636398A
(zh)
*
|
2007-02-05 |
2010-01-27 |
泽农医药公司 |
用于治疗钠通道介导的疾病或疾病状态的吡啶并嘧啶酮化合物
|
|
KR20090112720A
(ko)
|
2007-02-13 |
2009-10-28 |
헬신 세라퓨틱스 (유.에스.) 인크. |
성장 호르몬 분비촉진제를 이용한 세포 증식 질환의 치료방법
|
|
EP2178870B1
(en)
|
2007-08-17 |
2018-09-19 |
LG Chem, Ltd. |
Indole and indazole compounds as an inhibitor of cellular necrosis
|
|
US8536221B2
(en)
|
2008-02-07 |
2013-09-17 |
Abbvie Inc. |
Amide derivatives as positive allosteric modulators and methods of use thereof
|
|
ES2392796T3
(es)
*
|
2008-04-17 |
2012-12-13 |
Proximagen Limited |
Moduladores de tipo indol del receptor nicotínico de acetilcolina alfa-7
|
|
MX2010013399A
(es)
*
|
2008-06-06 |
2010-12-21 |
Abbott Lab |
Nuevos compuestos de 1,2,4-oxadiazol y sus metodos de uso.
|
|
US8318732B2
(en)
|
2008-07-02 |
2012-11-27 |
Avexa Limited |
Compounds having antiviral properties
|
|
EP2247601B1
(en)
|
2008-07-02 |
2013-04-10 |
Avexa Limited |
Thiazopyrimidinones and uses thereof
|
|
WO2010000031A1
(en)
|
2008-07-02 |
2010-01-07 |
Avexa Limited |
Imidazopyrimidinones and uses thereof
|
|
CN101628913B
(zh)
|
2008-07-18 |
2013-01-23 |
中国科学院广州生物医药与健康研究院 |
用作雌激素相关受体调节剂的化合物及其应用
|
|
UY32138A
(es)
*
|
2008-09-25 |
2010-04-30 |
Boehringer Ingelheim Int |
Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
|
|
WO2010074101A1
(ja)
*
|
2008-12-25 |
2010-07-01 |
住友化学株式会社 |
アミノピリジン化合物及びその用途
|
|
WO2010114898A1
(en)
|
2009-03-31 |
2010-10-07 |
Arqule, Inc. |
Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
|
|
US9040568B2
(en)
|
2009-05-29 |
2015-05-26 |
Abbvie Inc. |
Pharmaceutical compositions for the treatment of pain
|
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
|
CN102336751A
(zh)
|
2010-07-16 |
2012-02-01 |
爱维艾珂瑟有限公司 |
新型抗病毒剂
|
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
TW201245185A
(en)
|
2011-04-01 |
2012-11-16 |
Lundbeck & Co As H |
New positive allosteric modulators of nicotinic acetylcholine receptor
|
|
EP3406252B1
(en)
|
2012-02-10 |
2020-05-13 |
PTC Therapeutics, Inc. |
Compounds for treating spinal muscular atrophy
|
|
WO2014063199A1
(en)
|
2012-10-26 |
2014-05-01 |
Akaal Pharma Pty Ltd |
Organic compounds
|
|
WO2014148557A1
(ja)
|
2013-03-19 |
2014-09-25 |
凸版印刷株式会社 |
Ｅｇｆｒ阻害剤感受性予測方法
|
|
WO2015105657A1
(en)
*
|
2013-12-19 |
2015-07-16 |
Ptc Therapeutics, Inc. |
Methods for modulating the amount of rna transcripts
|
|
WO2015192761A1
(zh)
|
2014-06-17 |
2015-12-23 |
辰欣药业股份有限公司 |
作为mTOR/PI3K抑制剂的吡啶并[1,2-a]嘧啶酮类似物
|
|
CN106470992B
(zh)
|
2014-06-17 |
2018-11-06 |
正大天晴药业集团股份有限公司 |
作为pi3k抑制剂的吡啶并[1,2-a]嘧啶酮类似物
|
|
AR101674A1
(es)
|
2014-08-22 |
2017-01-04 |
Glaxosmithkline Ip Dev Ltd |
Uso de un compuesto tricíclico que contiene nitrógeno
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
EP3310169B1
(en)
|
2015-05-30 |
2023-05-17 |
PTC Therapeutics, Inc. |
Methods for modulating rna splicing
|
|
WO2017070464A1
(en)
*
|
2015-10-22 |
2017-04-27 |
Memorial Sloan-Kettering Cancer Center |
Cofactor analogs as methyltransferase inhibitors for treating cancer
|
|
US10919914B2
(en)
|
2016-06-08 |
2021-02-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2018053313A1
(en)
*
|
2016-09-19 |
2018-03-22 |
Memorial Sloan-Kettering Cancer Center |
Adenosine analogs as methyltransferase inhibitors for treating cancer
|
|
JP2019535789A
(ja)
|
2016-11-28 |
2019-12-12 |
ピーティーシー セラピューティクス，インコーポレーテッド |
Ｒｎａスプライシングを調節する方法
|
|
CN110520127B
(zh)
|
2017-03-26 |
2023-05-16 |
武田药品工业株式会社 |
作为gpr6的调节剂的经哌啶基取代的杂芳族羧酰胺和经哌嗪基取代的杂芳族羧酰胺
|
|
CN107349217B
(zh)
*
|
2017-07-21 |
2020-06-09 |
深圳大学 |
一种基于mettl3的小干扰rna及其药物和应用
|
|
EP3589745A1
(en)
*
|
2018-04-11 |
2020-01-08 |
Chemestmed Ltd. |
A method of modulating the rna methylation
|
|
JP7627209B2
(ja)
|
2018-08-14 |
2025-02-05 |
エピザイム，インコーポレイティド |
置換インドール及びその使用方法
|
|
WO2020112872A1
(en)
|
2018-11-30 |
2020-06-04 |
Epizyme, Inc. |
Methods of treating whsc1-overexpressing cancers by inhibiting setd2
|
|
CN109674792A
(zh)
*
|
2019-01-23 |
2019-04-26 |
四川大学 |
取代的5,6-二氢异喹啉并[3,2-α]异喹啉-7-鎓衍生物的用途
|
|
WO2020201773A1
(en)
*
|
2019-04-05 |
2020-10-08 |
Storm Therapeutics Ltd |
Mettl3 inhibitory compounds
|
|
US12195458B2
(en)
|
2019-12-02 |
2025-01-14 |
Storm Therapeutics Limited |
Polyheterocyclic compounds as METTL3 inhibitors
|